BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6653797)

  • 1. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia.
    Ayers JW; Gidwani GP
    Fertil Steril; 1983 Dec; 40(6):779-84. PubMed ID: 6653797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin secretion in benign breast diseases.
    Sitruk-Ware R; Clair F; Sterkers N; Ulmann A; Mauvais-Jarvis P
    Gynecol Endocrinol; 1987 Jun; 1(2):195-200. PubMed ID: 3140581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV; McDicken IW; Bulbrook RD; Moore JW; Taylor WH; George WD
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1345-51. PubMed ID: 6542005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S; Andersen AN; Blichert-Toft M
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal profile of benign breast disease and premenstrual mastodynia.
    Gorins A; Cordray JP
    Eur J Gynaecol Oncol; 1984; 5(1):1-10. PubMed ID: 6698047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormonal contraception and benign breast disease. Evaluation of a treatment protocol for chronic mastopathy with mastalgia].
    Leonardi M
    Minerva Ginecol; 1997 Jun; 49(6):271-6. PubMed ID: 9289667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormonal abnormalities in women with breast cysts].
    Wypych K; Kuźlik R; Wypych P
    Ginekol Pol; 2002 Nov; 73(11):1117-25. PubMed ID: 12722409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate luteal phase and benign breast disease.
    Marchesoni D; Gangemi M; Mozzanega B; Paternoster D; Graziottin A; Maggino T
    Clin Exp Obstet Gynecol; 1981; 8(4):160-3. PubMed ID: 7346187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine markers in benign breast diseases].
    Thalabard JC; Sitruk-Ware R; Kuttenn F; Mauvais-Jarvis P
    Zentralbl Gynakol; 1986; 108(6):354-8. PubMed ID: 3716674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.
    Parlati E; Travaglini A; Liberale I; Menini E; Dell'Acqua S
    J Endocrinol Invest; 1988 Oct; 11(9):679-83. PubMed ID: 2975693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia.
    Kumar S; Mansel RE; Scanlon MF; Hughes LE; Edwards CA; Woodhead JS; Newcombe RG
    Br J Surg; 1984 Nov; 71(11):870-3. PubMed ID: 6437468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast.
    Watt-Boolsen S; Eskildsen PC; Blaehr H
    Cancer; 1985 Aug; 56(3):500-2. PubMed ID: 4005811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin level abnormalities in women with cyclic mastalgia.
    Ecochard R; Marret H; Rabilloud M; Boehringer H; Mathieu C; Guerin JF
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):92-6. PubMed ID: 11134832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
    Rose DP; Boyar AP; Cohen C; Strong LE
    J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
    Zhou YZ; Jiang YX; Sun Q; Zhang SQ; Zhang Y; Chen FL; Lin SQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):609-13. PubMed ID: 12901108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.